Evidence map›Paper›PMID 40137881›Full record

ArticleToxins2025

Roland Josuran, Andreas Wenger, Sylvia Worbs, Bettina Kampa, Andreas Rummel, Brigitte G Dorner, Sabina Gerber

Abstract read
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roland JosuranInstitute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, 8820 Wädenswil, Switzerland.
Andreas WengerInstitute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, 8820 Wädenswil, Switzerland.
Sylvia WorbsBiological Toxins (ZBS3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany.
Bettina KampaBiological Toxins (ZBS3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany.
Andreas RummelInstitute of Toxicology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-0645-1641
Brigitte G DornerBiological Toxins (ZBS3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-5100-2546
Sabina GerberInstitute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, 8820 Wädenswil, Switzerland.ORCID 0009-0005-8875-4986

Funding

State Secretariat for Education, Research and Innovation SERI within the Federal Department of Economic Affairs, Education and Research EAER and the EUROPEAN COM-MISSION DIRECTORATE-GENERAL FOR MIGRATION AND HOME AFFAIRS Horizon 2020 research and innovati SERI No. 17.00055 and Grant Agreement No. 740189
6 · The paper itself

Abstract

Abrin is a highly toxic plant protein encompassing four isoforms, abrin-a, -b, -c and -d. An abrin reference material was isolated from

Indexed as

AbrinAbrusPolysaccharidesGlycosylationProtein IsoformsReference StandardsAbrinPolysaccharidesProtein Isoformsabrinabrin isoformsglycan profileN-glycosylation

Identifiers

PMID40137881
PMCPMC11945959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.